Brainsway Deep TMS Therapy - for Brain Disorder Treatment

Efficacy and safety of deep TMS for the treatment of resistant delusions in chronic schizophrenic patients.

Kfar Shaul Hospital, Jerusalem, Israel

08 March 2013

The aim of the study is to test whether Deep TMS with the H-coil to the right DLPC will alleviate refractory delusions in chronic schizophrenic patients. The pharmacological treatment of schizophrenia and other psychosis has improved markedly over the past 20 years. The second and third generation anti psychotics have improved clinical outcome in a significant proportion of patients. However the number of patients suffering from chronic psychosis remains high, many of them remaining in hospitals for prolonged periods of time. Other patients, although more functional and able to live in the community, continue to experience debilitating delusions and hallucinations.  We expect Deep TMS to be effective in reducing the delusional content of the thought in these patients, hopefully for extended periods of time.

Contact: Ben Draiman, benjamin.d@PSJER.HEALTH.GOV.IL

Principal Investigator: Dr. Sergay Raskin


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use